Effectiveness of mRNA vaccines in patients with cirrhosis with rising prevalence of SARS-CoV-2 delta variant

Binu V. John; Raphaella Ferreira; Dustin Bastaich; Akash Doshi; Tamar H. Taddei; David Kaplan; Seth A. Spector; Bassam Dahman

doi:10.1016/s0168-8278(22)00826-1

Article2021

SARS-CoV-2 Vaccines in Patients With Multiple Myeloma

Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Eleni Korompoki, Evangelos Terpos, Meletios A Dimopoulos

Preprint2023

SARS-CoV-2 VARIANT PREVALENCE ESTIMATION USING WASTEWATER SAMPLES

Ignacio López‐de‐Ullibarri, Lukas Tomas, Noelia Trigo‐Tasende, Bruna Moreira Freire, Manuel Vaamonde, Pilar Gallego‐García, Inés Barbeito, Juán A. Vallejo, Javier Tarrío‐Saavedra, Pilar Alvariño, E. Beade, Natalia Estévez, Soraya Rumbo‐Feal, Kelly Conde‐Pérez, Loretta De Chiara, Iago Iglesias‐Corrás, Margarita Poza, Susana Ladra, David Posada, Ricardo Cao

Article2024

Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study)

G Molnár, Zoltán Vokó, Gábor Sütő, György Rokszin, Dávid Nagy, György Surján, Orsolya Surján, Péter Nagy, István Kenessey, Andras Weber, Mihály Pálosi, Cecília Müller, Miklós Kásler, István Wittmann, Zoltán Kiss

Article2022

Effectiveness of COVID-19 viral vector vaccine Ad.26.COV2.S vaccine and comparison with mRNA vaccines in patients with cirrhosis

Binu V. John, Akash Doshi, Yangyang Deng, Natalie Mansour, A.Sidne Barritt, Andrew M. Moon, George N. Ioannou, Paul Martin, Hann‐Hsiang Chao, Tamar H. Taddei, David Kaplan, Bassam Dahman

Article2022

Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)

Zoltán Vokó, Zoltán Kiss, György Surján, Orsolya Surján, Zsófia Barcza, István Wittmann, G Molnár, Dávid Nagy, Veronika Müller, Krisztina Bogos, Péter Nagy, István Kenessey, Andras Weber, Lőrinc Polivka, Mihály Pálosi, János Szlávik, György Rokszin, Cecília Müller, Zoltán Szekanecz, Miklós Kásler

Effectiveness of mRNA vaccines in patients with cirrhosis with rising prevalence of SARS-CoV-2 delta variant

Discussion(0)

Related publications

SARS-CoV-2 Vaccines in Patients With Multiple Myeloma

SARS-CoV-2 VARIANT PREVALENCE ESTIMATION USING WASTEWATER SAMPLES

Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study)

Effectiveness of COVID-19 viral vector vaccine Ad.26.COV2.S vaccine and comparison with mRNA vaccines in patients with cirrhosis

Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)